Novel approaches to quantify defective interfering particle activity reveal a surrogate marker of interference in mammarenaviruses
Defective interfering particles (DIPs) profoundly influence viral replication and host responses yet it remains difficult to quantify their activity routinely in the laboratory. Here, using lymphocytic choriomeningitis virus (LCMV) as a model mammarenavirus, we establish complementary approaches for measuring interfering activity of DIPs across a range of experimental scales. First, we optimized plaque- and focus-based interference assays that directly quantify DIP-mediated suppression of standard infectious virus replication through a modified neutralization assay. Second, in cell monolayers saturated with both DIPs and infectious particles, we identified a complete loss of expression of the viral glycoprotein and matrix protein, which are each encoded in the positive-sense orientation of the mammarenavirus genome. Notably, this loss of protein expression mirrors the inhibition of plaque formation traditionally seen in this high DIP setting. The observed DIP-mediated loss of glycoprotein expression is a surrogate marker of interference and was used to develop an alternative assay of DIP activity. This glycoprotein expression assay recapitulated interference detected in traditional high-titer plaque assays (i.e. loss of plaques when all cells are saturated with DIPs and infectious particles) while substantially increasing scalability. These approaches enable sensitive and scalable quantification of DIP activity for LCMV as well as Junin virus and expand our experimental toolkit for studying arenavirus population dynamics, pathogenesis and immunity, and may help advance DIP-based antiviral strategies. This study also provides mechanistic details on how mammarenavirus DIPs interfere with infectious virus propagation.